
Validea's guru fundamental report indicates that Boston Scientific Corporation (BSX) receives a 100% rating based on their Quantitative Momentum Investor model, which is based on the strategy of Wesley Gray and favors stocks with strong, consistent intermediate-term relative performance. The model's high score suggests strong interest in BSX due to the firm's underlying fundamentals and stock valuation, with the stock passing tests for universe definition, momentum, and return consistency.
Boston Scientific Corporation (BSX) has received a perfect 100% rating from Validea's Quantitative Momentum Investor model, a system based on Wesley Gray's published strategy that identifies stocks exhibiting strong and consistent intermediate-term relative performance. This score signifies strong interest in BSX, as ratings above 90% are considered indicative of such. The positive assessment is attributed to the company's underlying fundamentals and current stock valuation. BSX, a large-cap growth stock within the Medical Equipment & Supplies industry, successfully met key criteria of this momentum strategy, including 'DEFINE THE UNIVERSE', 'TWELVE MINUS ONE MOMENTUM', and 'RETURN CONSISTENCY'. The 'SEASONALITY' factor was assessed as neutral. The overall sentiment towards BSX based on this report is strongly positive, with a bullish tone, underscoring the quantitative signals pointing towards favorable momentum characteristics.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment